Verified email-pattern data for Medicibio Co.,ltd is currently limited. You can still use the company insights and contact sections below.
MediciBIO Co., LTD is a biotechnology company, actively pursuing research in developing lipid-based nanoparticle (NP) platform technology and innovative new drugs for genetic diseases. Since its foundation in 2021, like the meaning of “the Medici Effect”, MediciBIO has derived innovative ideas through integrating DDS with nano-biotechnology, to create an innovative fusion technology in gene delivery area.
We research and develop “Medici Ionizable Lipid” and “Medici Targeting Lipid” as our unique gene carriers for next generation lipid nanoparticle (LNP). The LNP composed of Medici Ionizable Lipid, Medici-20 exhibits the superior gene delivery efficacy after IV injection in comparison to the LNPs composed of a FDA-approved ionizable lipid (MC-3 or SM-102), and notably have the significant lower and minimal immunogenicity and inflammation profiles as a carrier. Therefore, Medici-20 is eligible for the development of RNA or DNA therapeutics that necessitate multiple as well as frequently repeated administration even with inter-injection interval less than a week.
Another LNP composed of Medici ionizable lipid, Medici-305, demonstrates favorable localized gene delivery efficacy in muscle with a marked reduction in undesired systemic exposure after IM injection. The local delivery and reduced systemic exposure offered by an Medici-305-based LNP may potentially result in fewer excessive systemic reactogenicity, such as headache, systemic inflammation, fever, or fatigue. Therefore, Medici-305 can be used for infectious disease vaccines as well as cancer vaccines, while most of ionizable lipids are used only for infectious disease vaccines.
MediciBIO currently owns the patent rights for this structurally unique lipid; therefore, “Medici Lipid” can be used for independent product development with patent protections.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 184 Jungbu-Daero, Giheung-Gu, A-2207,korea, Republic Of
- Industry
- Biotechnology Research
- Website
- https://www.medicibio.com/
- HQ
- Yongin-si, Gyeonggi-do
Medicibio Co.,ltd Questions
MediciBIO Co.,LTD's website is https://www.medicibio.com/
MediciBIO Co.,LTD's LinkedIn profile is https://kr.linkedin.com/company/medicibio
MediciBIO Co.,LTD has
5 employees.
View email and phone details for 5
employees at MediciBIO Co.,LTD.
MediciBIO Co.,LTD's industry is
Biotechnology Research
MediciBIO Co.,LTD's top competitors are
Nadeno Nanoscience As,
Gempharmatech Asia Pacific,
Omega Therapeutics,
Akagera Medicines, Inc,
Korea Biomedical Review,
Toolgen Inc.,
Innopeutics Corporation,
Nanotis Corporation,
Institut Català De Nanociència I Nanotecnologia (Icn2),
Nanoprobes, Inc..
MediciBIO Co.,LTD's categories are Biotechnology Research
MediciBIO Co.,LTD's founding year is 2021
Explore related pages
Related company profiles:
Top MediciBIO Co.,LTD Employees
-
Jee-Young Park
Executive Director Business Development
South Korea, Korea, Republic Of1mail.nih.gov -
노진석
Medicibio Co.,Ltd
Yongin, Gyeonggi, South Korea, Korea, Republic Of
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.